Inogen, Inc.
INGNInogen, Inc. in brief
Inogen, Inc. is a listed company in the Medical Devices industry, based in California, USA. Its market value was $173 M on 22 October 2026, which makes it the 16,778th largest listed company in the world and the 3,239th largest in the USA on this site. In the year to December 2025 it had sales of $349 M and a net loss of $23 M. It employs about 1,021 people. By market, the largest shares of its 2025 sales came from USA (60%). Its shares trade under the symbol INGN (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Inogen, Inc.
Inogen provides Portable Oxygen Concentrators that are designed to offer a self replenishing, unlimited supply of oxygen that is concentrated from the surrounding air and to operate without the need for oxygen tanks or regular oxygen deliveries. It is operating in 46 countries. The headquarters is in USA.
Inogen, Inc. timeline
- 2004
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2014
- 🔔Initial public offering on NasdaqFinal prospectus filed with the SEC on 14 February 2014; shares registered for exchange trading on 10 February 2014.
- 2022
- 💰Record revenue of $377 millionFY2022, the highest of the 8 years on record.
- 2023
- 💰Record net income of $102 millionFY2023, the highest profit of the 7 years on record.
Events of Inogen, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #1,780 (Jan 2020) · #2,229 (Jan 2021) · #2,839 (Jan 2022) · #2,695 (Dec 2022) · #3,664 (Jul 2023) · #3,557 (Jan 2024) · #1,753 (Mar 2026) · #3,230 (Aug 2026) · #3,280 (Oct 2026) · #3,243 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 0.5×
- Price / book
- 0.9×
- Free cash flow yield
- -7.9%
- Net margin (TTM)
- -10.1%
- Operating margin
- -8.7%
- Return on equity
- -18.5%
- Liabilities / assets
- 35.6%
- Net debt
- $-57M
- Revenue growth
- +3.9%
- R&D / revenue
- 5.6%
- Revenue per employee
- $341 K
- Profit per employee
- $-22 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $349M | +3.9% | $-30M | $-23M | -6.5% |
| Dec 2024 | $336M | +6.3% | $-43M | $-36M | -10.7% |
| Dec 2023 | $316M | -16.3% | $-109M | $-102M | -32.5% |
| Dec 2022 | $377M | +5.4% | $-85M | $-84M | -22.2% |
| Dec 2021 | $358M | +16.0% | $9M | $-6M | -1.8% |
| Dec 2020 | $308M | -14.8% | $-12M | $-6M | -1.9% |
| Dec 2019 | $362M | +1.1% | $20M | $21M | 5.8% |
| Dec 2018 | $358M | — | $38M | $52M | 14.5% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-11M | $3M | $-14M | $-0.86 | — |
| Dec 2024 | $6M | $3M | $3M | $-1.52 | — |
| Dec 2023 | $-3M | $5M | $-8M | $-4.42 | — |
| Dec 2022 | $-38M | $3M | $-41M | $-3.67 | — |
| Dec 2021 | $24M | $5M | $18M | $-0.28 | — |
| Dec 2020 | $37M | $4M | $33M | $-0.27 | — |
| Dec 2019 | $41M | $3M | $37M | $0.94 | — |
| Dec 2018 | $60M | $8M | $52M | $2.30 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $77M (-2.4% on a year earlier), net income $-16M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 9, 202610-QQuarterly report · period to Sep 2026
- Nov 5, 20268-KCurrent reportAcquisition or disposal completed · Results of operations · Directors or officers changed · Regulation FD disclosure · Other events
- Sep 30, 20268-KCurrent reportMaterial agreement · Regulation FD disclosure · Other events
- Aug 7, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportResults of operations
- Jul 1, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
- Jun 11, 20268-KCurrent reportDirectors or officers changed · Shareholder vote
- May 8, 202610-QQuarterly report · period to Mar 2026
- May 7, 20268-KCurrent reportResults of operations
- Apr 28, 2026DEF 14AProxy statement
- Apr 6, 20268-KCurrent reportMaterial agreement · Directors or officers changed · Regulation FD disclosure
- Mar 30, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
Official filings of Inogen, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $349 M
- Operating income
- $-30 M
- Net income
- $-23 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $299 M
- Total liabilities
- $106 M
- Total equity
- $192 M
As of December-2025
Top 100 institutional investors in Inogen, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1,744,782 | -4,204 (-0.24%) | 6.71% | $9 M | Nov 13, 2026 |
| 2 | Armistice Capital, LLC | 1,236,000 | +140,000 (+12.77%) | 4.75% | $7 M | Nov 16, 2026 |
| 3 | Acadian Asset Management LLC | 1,096,879 | 0 (0.00%) | 4.22% | $6 M | Nov 9, 2026 |
| 4 | Vanguard Capital Management LLC | 1,038,316 | 0 (0.00%) | 3.99% | $5 M | Nov 13, 2026 |
| 5 | DAFNA Capital Management LLC | 845,179 | 0 (0.00%) | 3.25% | $4 M | Nov 16, 2026 |
| 6 | Arrowstreet Capital, Limited Partnership | 778,083 | +34,831 (+4.69%) | 2.99% | $4 M | Nov 13, 2026 |
| 7 | Morgan Stanley | 691,591 | +45,315 (+7.01%) | 2.66% | $4 M | Nov 13, 2026 |
| 8 | Jpmorgan Chase & Co | 679,870 | +199,562 (+41.55%) | 2.61% | $4 M | Nov 12, 2026 |
| 9 | AQR Capital Management LLC | 654,635 | -282,699 (-30.16%) | 2.52% | $3 M | Nov 16, 2026 |
| 10 | State Street Corp | 591,584 | -359 (-0.06%) | 2.28% | $3 M | Nov 12, 2026 |
| 11 | Federated Hermes, Inc. | 566,035 | +31,099 (+5.81%) | 2.18% | $3 M | Nov 12, 2026 |
| 12 | Goldman Sachs Group Inc | 558,309 | +122,724 (+28.17%) | 2.15% | $3 M | Nov 16, 2026 |
| 13 | Geode Capital Management, LLC | 534,536 | -106,985 (-16.68%) | 2.06% | $3 M | Nov 6, 2026 |
| 14 | Renaissance Technologies LLC | 479,000 | +2,300 (+0.48%) | 1.84% | $3 M | Nov 12, 2026 |
| 15 | Dimensional Fund Advisors LP | 455,886 | -32,759 (-6.70%) | 1.75% | $2 M | Nov 4, 2026 |
| 16 | CSM Advisors, LLC | 379,500 | -33,925 (-8.21%) | 1.46% | $2 M | Nov 13, 2026 |
| 17 | Citadel Advisors LLC | 323,009 | New | 1.24% | $2 M | Nov 16, 2026 |
| 18 | Jacobs Levy Equity Management, Inc | 322,163 | -66,625 (-17.14%) | 1.24% | $2 M | Nov 16, 2026 |
| 19 | Peapod Lane Capital LLC | 268,144 | +5,369 (+2.04%) | 1.03% | $1 M | Oct 22, 2026 |
| 20 | Vanguard Portfolio Management LLC | 256,907 | +4,151 (+1.64%) | 0.99% | $1 M | Nov 13, 2026 |
| 21 | Readystate Asset Management LP | 246,110 | -20,224 (-7.59%) | 0.95% | $1 M | Nov 16, 2026 |
| 22 | Point72 Asset Management, L.P. | 227,336 | +55,994 (+32.68%) | 0.87% | $1 M | Nov 16, 2026 |
| 23 | Moore Capital Management, LP | 225,233 | -63,895 (-22.10%) | 0.87% | $1 M | Nov 16, 2026 |
| 24 | Steward Partners Investment Advisory, LLC | 205,181 | +3,650 (+1.81%) | 0.79% | $1 M | Nov 13, 2026 |
| 25 | Quantinno Capital Management LP | 202,882 | +70,155 (+52.86%) | 0.78% | $1 M | Nov 13, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Bridgeway Capital Management, LLC | 194,429 | -622 (-0.32%) | 0.75% | $1 M | Nov 16, 2026 |
| 27 | Northern Trust Corp | 192,469 | -4,777 (-2.42%) | 0.74% | $1 M | Nov 16, 2026 |
| 28 | UBS Group AG | 191,516 | -110,080 (-36.50%) | 0.74% | $1 M | Nov 10, 2026 |
| 29 | Vanguard Fiduciary Trust Co | 169,470 | +5,712 (+3.49%) | 0.65% | $1 M | Nov 13, 2026 |
| 30 | Prudential Financial Inc | 167,170 | -161,800 (-49.18%) | 0.64% | $1 M | Nov 16, 2026 |
| 31 | Nuveen, LLC | 163,573 | -21,999 (-11.85%) | 0.63% | $1 M | Nov 10, 2026 |
| 32 | Marshall Wace, LLP | 160,815 | New | 0.62% | $1 M | Nov 13, 2026 |
| 33 | Monaco Asset Management SAM | 135,742 | -25,000 (-15.55%) | 0.52% | $1 M | Nov 9, 2026 |
| 34 | Russell Investments Group, Ltd. | 133,294 | +101,214 (+315.50%) | 0.51% | $1 M | Nov 6, 2026 |
| 35 | Bank of New York Mellon Corp | 117,989 | -401 (-0.34%) | 0.45% | $1 M | Nov 5, 2026 |
| 36 | D. E. Shaw & Co., Inc. | 117,899 | +80,728 (+217.18%) | 0.45% | $1 M | Nov 16, 2026 |
| 37 | Credit Agricole S A | 112,000 | 0 (0.00%) | 0.43% | $1 M | Nov 13, 2026 |
| 38 | Ameriprise Financial Inc | 108,987 | -874,041 (-88.91%) | 0.42% | $1 M | Nov 16, 2026 |
| 39 | Tocqueville Asset Management L.P. | 93,350 | 0 (0.00%) | 0.36% | $0 M | Nov 13, 2026 |
| 40 | Charles Schwab Investment Management Inc | 81,369 | +7,204 (+9.71%) | 0.31% | $0 M | Nov 16, 2026 |
| 41 | Connor, Clark & Lunn Investment Management Ltd. | 71,016 | +29,431 (+70.77%) | 0.27% | $0 M | Nov 10, 2026 |
| 42 | Invesco Ltd. | 66,728 | +5,340 (+8.70%) | 0.26% | $0 M | Nov 12, 2026 |
| 43 | American Century Companies Inc | 60,356 | -479 (-0.79%) | 0.23% | $0 M | Nov 12, 2026 |
| 44 | Mackenzie Financial Corp | 58,697 | -152,163 (-72.16%) | 0.23% | $0 M | Nov 2, 2026 |
| 45 | Alliancebernstein L.P. | 57,920 | 0 (0.00%) | 0.22% | $0 M | Nov 16, 2026 |
| 46 | Panagora Asset Management Inc | 53,714 | +1,291 (+2.46%) | 0.21% | $0 M | Nov 12, 2026 |
| 47 | BNP Paribas Financial Markets | 51,610 | -12,834 (-19.91%) | 0.20% | $0 M | Nov 12, 2026 |
| 48 | Barclays PLC | 48,334 | +5,727 (+13.44%) | 0.19% | $0 M | Nov 6, 2026 |
| 49 | Campbell & CO Investment Adviser LLC | 47,893 | -15,923 (-24.95%) | 0.18% | $0 M | Nov 13, 2026 |
| 50 | XTX Topco Ltd | 45,696 | +2,320 (+5.35%) | 0.18% | $0 M | Nov 16, 2026 |
| 51 | Assenagon Asset Management S.A. | 44,185 | -129,695 (-74.59%) | 0.17% | $0 M | Oct 15, 2026 |
| 52 | Mercer Global Advisors Inc /adv | 42,571 | +11,634 (+37.61%) | 0.16% | $0 M | Nov 16, 2026 |
| 53 | Price T Rowe Associates Inc /MD/ | 41,669 | +3,526 (+9.24%) | 0.16% | $0 M | Nov 16, 2026 |
| 54 | Bank Of America Corp /de/ | 38,706 | +5,823 (+17.71%) | 0.15% | $0 M | Nov 16, 2026 |
| 55 | Ieq Capital, LLC | 38,407 | -35,182 (-47.81%) | 0.15% | $0 M | Nov 10, 2026 |
| 56 | Polar Asset Management Partners Inc. | 37,995 | New | 0.15% | $0 M | Nov 16, 2026 |
| 57 | Corient Private Wealth LP | 37,745 | New | 0.15% | $0 M | Nov 16, 2026 |
| 58 | Empowered Funds, LLC | 36,078 | New | 0.14% | $0 M | Nov 13, 2026 |
| 59 | FMR LLC | 35,530 | +18,147 (+104.40%) | 0.14% | $0 M | Nov 10, 2026 |
| 60 | Millennium Management LLC | 30,424 | +6,856 (+29.09%) | 0.12% | $0 M | Nov 16, 2026 |
| 61 | Prelude Capital Management, LLC | 30,386 | +15,728 (+107.30%) | 0.12% | $0 M | Nov 16, 2026 |
| 62 | Rhumbline Advisers | 29,349 | -257 (-0.87%) | 0.11% | $0 M | Nov 10, 2026 |
| 63 | Susquehanna International Group, LLP | 28,915 | +18,514 (+178.00%) | 0.11% | $0 M | Nov 16, 2026 |
| 64 | Tidal Investments LLC | 27,657 | +1,683 (+6.48%) | 0.11% | $0 M | Nov 13, 2026 |
| 65 | Occudo Quantitative Strategies LP | 26,528 | New | 0.10% | $0 M | Nov 16, 2026 |
| 66 | HSBC Holdings PLC | 25,957 | -17,849 (-40.75%) | 0.10% | $0 M | Nov 16, 2026 |
| 67 | HRT Financial LP | 25,316 | New | 0.10% | $0 M | Nov 13, 2026 |
| 68 | Cerity Partners LLC | 22,860 | -8,693 (-27.55%) | 0.09% | $0 M | Nov 13, 2026 |
| 69 | Deutsche Bank AG\ | 21,104 | -3,049 (-12.62%) | 0.08% | $0 M | Nov 6, 2026 |
| 70 | AlphaCore Capital LLC | 20,974 | +99 (+0.47%) | 0.08% | $0 M | Nov 4, 2026 |
| 71 | Savant Capital, LLC | 20,514 | New | 0.08% | $0 M | Nov 6, 2026 |
| 72 | Jane Street Group, LLC | 18,844 | +2,668 (+16.49%) | 0.07% | $0 M | Nov 12, 2026 |
| 73 | Divisadero Street Capital Management, LP | 18,413 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 74 | Two Sigma Investments, LP | 18,180 | +3,165 (+21.08%) | 0.07% | $0 M | Nov 16, 2026 |
| 75 | Engineers Gate Manager LP | 17,900 | New | 0.07% | $0 M | Nov 16, 2026 |
| 76 | Aigen Investment Management, LP | 17,196 | +6,855 (+66.29%) | 0.07% | $0 M | Nov 16, 2026 |
| 77 | Quadrature Capital Ltd | 17,188 | +7,038 (+69.34%) | 0.07% | $0 M | Nov 13, 2026 |
| 78 | Integrated Wealth Concepts LLC | 16,873 | +145 (+0.87%) | 0.06% | $0 M | Nov 17, 2026 |
| 79 | Wealth Enhancement Advisory Services, LLC | 15,954 | -7,407 (-31.71%) | 0.06% | $0 M | Oct 13, 2026 |
| 80 | Mariner, LLC | 14,975 | -15,121 (-50.24%) | 0.06% | $0 M | Nov 12, 2026 |
| 81 | Bank Of Montreal /can/ | 14,905 | New | 0.06% | $0 M | Nov 9, 2026 |
| 82 | Royce & Associates LP | 14,529 | New | 0.06% | $0 M | Nov 9, 2026 |
| 83 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 12,002 | +603 (+5.29%) | 0.05% | $0 M | Nov 16, 2026 |
| 84 | Arax Advisory Partners | 10,683 | -1,022 (-8.73%) | 0.04% | $0 M | Nov 12, 2026 |
| 85 | Vanguard Personalized Indexing Management, LLC | 10,334 | New | 0.04% | $0 M | Nov 16, 2026 |
| 86 | Vanguard Global Advisers, LLC | 8,195 | +90 (+1.11%) | 0.03% | $0 M | Nov 13, 2026 |
| 87 | New York State Common Retirement Fund | 7,397 | 0 (0.00%) | 0.03% | $0 M | Nov 17, 2026 |
| 88 | Police & Firemen's Retirement System of New Jersey | 7,043 | 0 (0.00%) | 0.03% | $0 M | Nov 9, 2026 |
| 89 | PNC Financial Services Group, Inc. | 6,689 | +5,125 (+327.69%) | 0.03% | $0 M | Nov 6, 2026 |
| 90 | Tower Research Capital LLC (TRC) | 5,867 | +3,842 (+189.73%) | 0.02% | $0 M | Nov 16, 2026 |
| 91 | Wells Fargo & Company/mn | 4,813 | -15,918 (-76.78%) | 0.02% | $0 M | Nov 16, 2026 |
| 92 | Employees Retirement System of Texas | 4,008 | New | 0.02% | $0 M | Nov 10, 2026 |
| 93 | Walleye Capital LLC | 3,968 | New | 0.02% | $0 M | Nov 13, 2026 |
| 94 | Nisa Investment Advisors, LLC | 3,579 | -2,558 (-41.68%) | 0.01% | $0 M | Oct 20, 2026 |
| 95 | Pinnacle Wealth Planning Services, Inc. | 3,534 | +1,317 (+59.40%) | 0.01% | $0 M | Oct 27, 2026 |
| 96 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2,283 | +2,172 (+1956.76%) | 0.01% | $0 M | Nov 16, 2026 |
| 97 | Versant Capital Management, Inc | 2,204 | -1,776 (-44.62%) | 0.01% | $0 M | Oct 2, 2026 |
| 98 | Legal & General Group Plc | 2,134 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 99 | GAMMA Investing LLC | 1,678 | +920 (+121.37%) | 0.01% | $0 M | Oct 8, 2026 |
| 100 | Ameritas Investment Partners, Inc. | 1,598 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
Mutual funds holding Inogen, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 739,966 | $5 M | 2.8% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Columbia Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC | 644,211 | $4 M | 2.5% | 0.17% | +6.5% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 643,736 | $4 M | 2.5% | <0.01% | +11% | Jun 30, 2026 |
| 🇺🇸 Federated Hermes MDT Small Cap Core FundFederated Hermes MDT Series | 371,379 | $2 M | 1.4% | 0.11% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 271,196 | $2 M | 1.0% | <0.01% | +2.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 267,300 | $2 M | 1.0% | <0.01% | +14% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 219,250 | $1 M | 0.84% | <0.01% | +9.1% | Jun 30, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 133,234 | $1 M | 0.51% | <0.01% | −57% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 130,575 | $1 M | 0.50% | <0.01% | +3.6% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 122,742 | $1 M | 0.47% | <0.01% | +4.6% | May 31, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 120,640 | $1 M | 0.46% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Columbia Variable Portfolio - Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC | 116,530 | $1 M | 0.45% | 0.17% | −3.4% | Jun 30, 2026 |
| 🇺🇸 JPMorgan U.S. Small Company FundJ.P. Morgan Investment Management Inc. | 94,635 | $1 M | 0.36% | 0.05% | −6.7% | Jun 30, 2026 |
| 🇺🇸 Vanguard Strategic Small-Cap Equity FundThe Vanguard Group, Inc. | 88,572 | $1 M | 0.34% | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 84,571 | $1 M | 0.33% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 82,873 | $1 M | 0.32% | 0.04% | +40% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Value Insights FundGoldman Sachs Asset Management, L.P. | 82,529 | $1 M | 0.32% | 0.04% | −48% | Jul 31, 2026 |
| 🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc. | 81,693 | $1 M | 0.31% | 0.04% | new | Jun 30, 2026 |
| 🇺🇸 AST PGIM Aggressive Multi-Asset PortfolioAST Investment Services, Inc. | 73,600 | $0 M | 0.28% | <0.01% | −23% | Jun 30, 2026 |
| 🇺🇸 Federated Hermes MDT Small Cap Core ETFFederated Advisory Services Company | 68,219 | $0 M | 0.26% | 0.16% | +73% | May 31, 2026 |
| 🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I | 66,808 | $0 M | 0.26% | 0.03% | +43% | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 58,994 | $0 M | 0.23% | <0.01% | −35% | Jul 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 57,562 | $0 M | 0.22% | <0.01% | +12% | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 49,112 | $0 M | 0.19% | 0.03% | +688% | Jul 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 48,644 | $0 M | 0.19% | 0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 47,819 | $0 M | 0.18% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS | 47,221 | $0 M | 0.18% | 0.07% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 41,509 | $0 M | 0.16% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 41,210 | $0 M | 0.16% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS | 39,730 | $0 M | 0.15% | 0.12% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC | 38,419 | $0 M | 0.15% | 0.02% | +6.8% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 37,544 | $0 M | 0.14% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 36,700 | $0 M | 0.14% | 0.16% | no change | Jun 30, 2026 |
| 🇺🇸 Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value FundFederated Hermes Equity Funds | 36,114 | $0 M | 0.14% | 0.13% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 34,352 | $0 M | 0.13% | 0.01% | +17% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 32,057 | $0 M | 0.12% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 32,045 | $0 M | 0.12% | <0.01% | −9.3% | Jul 31, 2026 |
| 🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP | 28,702 | $0 M | 0.11% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 28,312 | $0 M | 0.11% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 27,333 | $0 M | 0.11% | <0.01% | +76% | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 26,640 | $0 M | 0.10% | <0.01% | +15% | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 23,720 | $0 M | 0.09% | <0.01% | +17% | Jun 30, 2026 |
| 🇺🇸 LVIP JPMorgan Small Cap Core FundLincoln Financial Investments Corporation | 21,118 | $0 M | 0.08% | 0.06% | −5.4% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC | 20,568 | $0 M | 0.08% | 0.04% | new | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc. | 20,000 | $0 M | 0.08% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 18,133 | $0 M | 0.07% | <0.01% | +4.7% | May 31, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 16,555 | $0 M | 0.06% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 14,790 | $0 M | 0.06% | <0.01% | −20% | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 14,132 | $0 M | 0.05% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 13,936 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vy Jpmorgan Small Cap Core Equity PortfolioVoya Investments, LLC | 13,901 | $0 M | 0.05% | 0.03% | −5.0% | Jun 30, 2026 |
| 🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC | 13,324 | $0 M | 0.05% | 0.02% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 13,218 | $0 M | 0.05% | <0.01% | −26% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 12,467 | $0 M | 0.05% | <0.01% | −4.1% | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 12,246 | $0 M | 0.05% | <0.01% | −49% | May 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC | 11,869 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 11,822 | $0 M | 0.05% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 11,633 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 10,056 | $0 M | 0.04% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP | 10,041 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 9,219 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 8,576 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 8,643 | $0 M | 0.03% | <0.01% | +2.6% | Jul 31, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 8,497 | $0 M | 0.03% | <0.01% | +1360% | Jun 30, 2026 |
| 🇺🇸 PGIM Balanced FundPrudential Investment Portfolios, Inc. | 8,400 | $0 M | 0.03% | <0.01% | −18% | Jun 30, 2026 |
| 🇺🇸 Avantis Total Equity Markets ETFAmerican Century ETF Trust | 7,360 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 7,292 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 6,801 | $0 M | 0.03% | <0.01% | +39% | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 6,640 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 5,741 | $0 M | 0.02% | 0.02% | −81% | Jun 30, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 5,687 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 5,637 | $0 M | 0.02% | 0.02% | +34% | Jun 30, 2026 |
| 🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc. | 4,940 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP | 4,900 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 4,690 | $0 M | 0.02% | <0.01% | −0.7% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 4,635 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SA Multi-Managed Small Cap PortfolioSunAmerica Asset Management, LLC | 4,462 | $0 M | 0.02% | 0.02% | −9.1% | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 4,100 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 4,039 | $0 M | 0.02% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 4,014 | $0 M | 0.02% | <0.01% | +38% | Jun 30, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 3,941 | $0 M | 0.02% | <0.01% | +24% | Jun 30, 2026 |
| 🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 3,896 | $0 M | 0.01% | <0.01% | −0.2% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 3,731 | $0 M | 0.01% | <0.01% | +57% | Jun 30, 2026 |
| 🇺🇸 EQ/Common Stock Index PortfolioEquitable Investment Management Group, LLC | 3,600 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 3,522 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP | 3,394 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC | 3,333 | $0 M | 0.01% | <0.01% | +18% | May 31, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 3,200 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP | 3,192 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 3,040 | $0 M | 0.01% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP | 3,001 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP | 2,852 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust | 2,676 | $0 M | 0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 2,678 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 2,564 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,240 | $0 M | <0.01% | <0.01% | +45% | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 2,200 | $0 M | <0.01% | <0.01% | +22% | May 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust | 2,116 | $0 M | <0.01% | 0.01% | no change | May 31, 2026 |
| 🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC | 2,029 | $0 M | <0.01% | <0.01% | +131% | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 1,970 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Inogen, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Smith Kevin Raymond MerrillCEO and President, Director | Grant or award10b5-1 plan | +1,500 | $5.330 | $8 K | 134,962 | Form 4 |
| filed | Mary E. WrightVP, Chief Accounting Officer | Grant or award | +1,500 | $5.330 | $8 K | 20,629 | Form 4 |
| filed | Kevin P. SmithEVP, Bus Dev, GC & Sec | Grant or award10b5-1 plan | +1,500 | $5.330 | $8 K | 23,507 | Form 4 |
| filed | Kevin P. SmithEVP, Bus Dev, GC & Sec | Option exercise10b5-1 plan | +18,136 | — | — | 41,643 | Form 4 |
| filed | Kevin P. SmithEVP, Bus Dev, GC & Sec | Shares withheld for tax10b5-1 plan | -8,671 | $5.330 | $46 K | 32,972 | Form 4 |
| filed | Boyer Jennifer M. YiEVP Entrprs Enblmnt, Ch HR Off | Sell10b5-1 plan | -10,938 | $6.600 | $72 K | 5,039 | Form 4 |
| filed | Kevin M. KingDirector | Grant or award | +28,081 | — | — | 104,966 | Form 4 |
| filed | Mira Kirti SahneyDirector | Grant or award | +28,081 | — | — | 67,805 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Inogen, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q3 2026 | $3.7M |
| Q2 2026 | Q2 2026 | $5.6M |
| Q1 2026 | Q1 2026 | $1.9M |
Trading halts
- 2026-11-06 14:32 UTC, code LUDP, resumed 14:37 UTC
Fails to deliver
- : 99 shares at $6.67
- : 734 shares at $5.77
- : 278 shares at $5.27
- : 15,156 shares at $5.56
- : 20 shares at $5.50
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Inogen, Inc. scorecard#
Passes 6 of the 20 checks that could be worked out: strongest in valuation (2 of 5), weakest in profitability (1 of 5). Fiscal year 2025; market cap of Oct 22, 2026.
Valuation2 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median0.9×Price to book 0.9× against Medical Devices's median of 2.5×.
- ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%-7.9%Free cash flow is -7.9% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth2 of 6
- ✓Revenue grew in the newest year3.9%Revenue up 3.9% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years-2.6%-2.6% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median-2.6%-2.6% a year against Medical Devices's median of 10.8% (73 companies).
- ✗Earnings per share grew in the newest year-0.86 vs -1.52Diluted EPS -0.86 in fiscal 2025 against -1.52 the year before (report's currency).
- ✗Net income higher than five years earlier-$23 M-$23 M in fiscal 2025 against -$6 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability1 of 5
- ✗Profitable in the newest year-$23 MNet income -$23 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-8.7%-8.7% against Medical Devices's median of -8.2% (86 companies).
- ✗Return on equity above 15%-12.4%-12.4% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-8.7%-8.7% in fiscal 2025 against -22.6% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities3.5×Current ratio 3.53 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone1.64Z-score 1.64 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year12.5%Diluted shares up 12.5% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Inogen, Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -8.7% | -8.2% | |
| Net margin | -6.5% | -10.4% | |
| Return on equity | -12.4% | -16.8% | |
| Revenue growth, 3 years a year | -2.6% | 10.8% | |
| Revenue growth | 3.9% | 10.4% | |
| Free cash flow margin | -3.9% | -1.9% |
4of 8on the Piotroski tests of financial strength
- Net loss of $23 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$14 million.
- The share count rose 12.5% in the year.
Inogen, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 349+3.9%100% | 336+6.4%100% | 316−16.3%100% | 377+5.4%100% | 358+16.1%100% | 308−14.8%100% | 362+1.1%100% | 358+43.6%100% | 249+23.0%100% | 203—100% | |
| Cost of revenue | 194+7.4%55.8% | 181−4.2%53.9% | 189−15.5%59.9% | 224+23.2%59.3% | 182+6.6%50.7% | 170−10.4%55.2% | 190+5.9%52.5% | 180+40.0%50.1% | 128+21.5%51.4% | 106—52.0% | |
| Gross profit | 154−0.3%44.2% | 155+22.1%46.1% | 127−17.5%40.1% | 154−13.0%40.7% | 176+27.7%49.3% | 138−19.6%44.8% | 172−3.8%47.5% | 179+47.3%49.9% | 121+24.6%48.6% | 97—48.0% | |
| Research and development | 19−10.2%5.6% | 22+3.7%6.4% | 21−5.0%6.6% | 22+32.4%5.8% | 17+17.7%4.6% | 14+49.8%4.6% | 9.4+33.7%2.6% | 7.0+32.3%2.0% | 5.3+3.9%2.1% | 5.1—2.5% | |
| Selling and marketing | 98−5.2%28.0% | 103−3.8%30.7% | 107−11.3%33.9% | 121+7.0%32.0% | 113+15.7%31.5% | 98−7.6%31.6% | 106+10.4%29.2% | 96+88.4%26.7% | 51+35.2%20.3% | 38—18.5% | |
| General and administrative | 67−7.2%19.3% | 73−3.6%21.6% | 75+71.4%23.8% | 44+16.0%11.6% | 38−2.0%10.6% | 39+4.0%12.5% | 37−2.4%10.3% | 38+1.2%10.6% | 38+18.2%15.1% | 32—15.7% | |
| Operating expenses | 184−6.5%52.9% | 197−16.4%58.8% | 236−1.1%74.8% | 239+42.8%63.3% | 167+11.3%46.7% | 150−1.2%48.7% | 152+8.1%42.0% | 141+50.2%39.3% | 94+25.8%37.5% | 74—36.7% | |
| Operating income | −30—−8.7% | −43—−12.7% | −109—−34.7% | −85−1023%−22.6% | 9.2—2.6% | −12−161%−3.9% | 20−47.8%5.5% | 38+37.3%10.6% | 28+20.7%11.1% | 23—11.3% | |
| Interest and finance income | 4.4−15.5%1.3% | 5.2−21.1%1.5% | 6.6+132%2.1% | 2.8+2099%0.8% | 0.1−85.8%0.0% | 0.9−80.7%0.3% | 4.7+44.6%1.3% | 3.3+326%0.9% | 0.8+290%0.3% | 0.2—0.1% | |
| Interest expense and finance costs | — | — | — | — | — | — | — | — | — | 0.0—0.0% | |
| Other non-operating income (expense) | 6.8+13.0%2.0% | 6.0−14.2%1.8% | 7.0+257%2.2% | 2.0—0.5% | −0.6−109%−0.2% | 6.7+50.5%2.2% | 4.5+74.9%1.2% | 2.6+24.1%0.7% | 2.1—0.8% | −0.1—−0.1% | |
| Income before tax | −23—−6.7% | −36—−10.9% | −102—−32.4% | −83−1062%−22.1% | 8.7—2.4% | −5.3−122%−1.7% | 24−40.0%6.7% | 40+36.4%11.3% | 30+30.5%11.9% | 23—11.2% | |
| Income tax | −0.6—−0.2% | −0.6−660%−0.2% | 0.1−79.2%0.0% | 0.5−96.6%0.1% | 15+2631%4.2% | 0.5−83.5%0.2% | 3.3—0.9% | −11−232%−3.2% | 8.7+292%3.5% | 2.2—1.1% | |
| Net income attributable to shareholders | −23—−6.5% | −36—−10.7% | −102—−32.5% | −84—−22.2% | −6.3—−1.8% | −5.8−128%−1.9% | 21−59.6%5.8% | 52+147%14.5% | 21+2.4%8.4% | 21—10.1% | |
| Earnings per share, basic | -0.86—— | -1.52—— | -4.42—— | -3.67—— | -0.28—— | -0.27−128%— | 0.96−60.7%— | 2.44+139%— | 1.020.0%— | 1.02—— | |
| Earnings per share, diluted | -0.86—— | -1.52—— | -4.42—— | -3.67—— | -0.28—— | -0.27−129%— | 0.94−59.1%— | 2.30+140%— | 0.96−1.0%— | 0.97—— | |
| Shares, weighted average (basic) | 27+12.5%— | 24+2.1%— | 23+1.4%— | 23+1.6%— | 22+2.3%— | 22+0.7%— | 22+2.6%— | 21+2.8%— | 21+3.1%— | 20—— | |
| Shares, weighted average (diluted) | 27+12.5%— | 24+2.1%— | 23+1.4%— | 23+1.6%— | 22+2.3%— | 22−1.2%— | 22−1.2%— | 23+2.8%— | 22+3.8%— | 21—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 104−8.8%34.7% | 114−9.3%38.4% | 125−32.9%38.5% | 187−20.6%46.2% | 236+11.1%48.1% | 212+7.0%45.9% | 198+0.7%44.3% | 197+37.6%52.3% | 143+54.0%52.0% | 93—43.4% | |
| Short-term investments | 16—5.3% | 0−100%0.0% | 3.0—0.9% | — | 10.0−48.1%2.0% | 19+74.2%4.2% | 11−74.7%2.5% | 44+41.1%11.6% | 31+47.3%11.3% | 21—9.8% | |
| Receivables | 34r39+15.5%11.4% | 30−30.0%10.0% | 42−32.7%12.9% | 63+157%15.5% | 24−17.7%5.0% | 30−13.4%6.4% | 34−7.3%7.7% | 37+17.8%9.9% | 31+2.0%11.4% | 31—14.4% | |
| Inventory | 26+4.7%8.7% | 25+13.6%8.4% | 22−35.9%6.7% | 34+7.0%8.4% | 32+28.4%6.5% | 25−30.4%5.4% | 36+31.7%8.0% | 27+43.7%7.2% | 19+31.4%6.8% | 14—6.7% | |
| Other current assets | 11r13−17.0%3.8% | 14r13−1.3%4.6% | 14−27.8%4.2% | 19−26.2%4.7% | 26+45.3%5.3% | 18+76.2%3.9% | 10+36.1%2.3% | 7.5r7.1+189%2.0% | 2.6+55.8%0.9% | 1.7—0.8% | |
| Current assets | 225r198+21.1%75.2% | 185−10.4%62.6% | 207−32.0%63.5% | 305−7.5%75.2% | 329+7.7%67.2% | 306+4.6%66.2% | 292−7.1%65.3% | 315+37.7%83.7% | 228+41.4%83.1% | 162—75.5% | |
| Property, plant and equipment | 10r36−77.3%3.4% | 44−11.8%15.0% | 50+16.3%15.4% | 43+11.2%10.7% | 39+37.9%8.0% | 28+45.2%6.1% | 19−13.0%4.3% | 22+11.1%5.9% | 20−20.2%7.3% | 25—11.8% | |
| Right-of-use (leased) assets | 17−9.8%5.5% | 18−10.0%6.2% | 20−6.1%6.2% | 22−13.1%5.3% | 25+182%5.1% | 8.8+50.8%1.9% | 5.9—1.3% | — | — | — | |
| Goodwill | 11+13.0%3.6% | 9.5−5.9%3.2% | 10−69.4%3.1% | 33−0.4%8.1% | 33−0.6%6.7% | 33+0.6%7.2% | 33+1360%7.4% | 2.3−4.5%0.6% | 2.4—0.9% | — | |
| Other intangible assets | 31+0.9%10.3% | 30−11.8%10.3% | 35+19443%10.6% | 0.2−99.7%0.0% | 60−12.6%12.3% | 69−11.3%14.9% | 78+1965%17.3% | 3.8−20.4%1.0% | 4.7+1857%1.7% | 0.2—0.1% | |
| Total assets | 299+0.8%100% | 296−9.2%100% | 326−19.5%100% | 405−17.3%100% | 490+6.0%100% | 462+3.2%100% | 447+19.0%100% | 376+36.7%100% | 275+28.5%100% | 214—100% | |
| Accounts payable | 20r20+18.8%6.6% | 17+23.5%5.6% | 13−26.2%4.1% | 18+77.8%4.5% | 10−18.1%2.1% | 13−23.7%2.7% | 16+19.5%3.7% | 14+43.8%3.6% | 9.5+66.3%3.5% | 5.7—2.7% | |
| Current liabilities | 64−17.1%21.3% | 77+5.8%25.9% | 72+10.9%22.2% | 65+6.2%16.1% | 62+8.5%12.6% | 57+13.0%12.3% | 50+7.7%11.2% | 47+37.5%12.4% | 34+48.3%12.3% | 23—10.7% | |
| Lease liabilities (non-current) | 14−13.7%4.8% | 17−9.2%5.6% | 18−7.6%5.6% | 20−15.1%4.9% | 23+188%4.8% | 8.1+71.8%1.7% | 4.7—1.1% | — | — | — | |
| Total liabilities | 106−13.0%35.6% | 122+0.8%41.3% | 121+12.8%37.2% | 108−9.8%26.6% | 119+6.3%24.4% | 112+9.3%24.3% | 103+56.9%23.0% | 65+36.3%17.4% | 48+50.3%17.5% | 32—14.9% | |
| Retained earnings | −176—−58.8% | −153—−51.6% | −117—−35.9% | −15−121%−3.6% | 69−8.4%14.2% | 76−7.2%16.4% | 81+34.6%18.2% | 60+600%16.1% | 8.6—3.1% | −12—−5.8% | |
| Shareholders' equity | 192+10.6%64.4% | 174−15.1%58.7% | 205−31.1%62.8% | 297−19.7%73.4% | 370+5.9%75.6% | 350+1.5%75.7% | 345+11.0%77.0% | 310+36.7%82.6% | 227+24.7%82.5% | 182—85.1% | |
| Total liabilities and equity | 299+0.8%100% | 296−9.2%100% | 326−19.5%100% | 405−17.3%100% | 490+6.0%100% | 462+3.2%100% | 447+19.0%100% | 376+36.7%100% | 275+28.5%100% | 214—100% | |
| Shares outstanding | 27+13.9%— | 24+2.5%— | 23+1.7%— | 23+0.9%— | 23+2.7%— | 22+0.5%— | 22+1.2%— | 22+3.8%— | 21+2.9%— | 20—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 21−1.6%5.9% | 21+15.7%6.3% | 18−22.8%5.8% | 24+8.7%6.2% | 22+16.4%6.0% | 19+34.3%6.0% | 14+22.5%3.8% | 11−8.2%3.2% | 12−9.3%4.9% | 14—6.7% | |
| Share-based compensation | 8.0+8.3%2.3% | 7.4−0.4%2.2% | 7.4−39.5%2.4% | 12+12.2%3.3% | 11+33.4%3.1% | 8.2−10.1%2.7% | 9.1−28.6%2.5% | 13+32.7%3.6% | 9.6+32.2%3.9% | 7.3—3.6% | |
| Cash from operating activities | −11−290%−3.2% | 5.9—1.8% | −3.2—−1.0% | −38−259%−9.9% | 24−36.1%6.6% | 37−8.8%12.0% | 41−32.3%11.2% | 60−0.9%16.7% | 60+94.9%24.3% | 31—15.3% | |
| Capital expenditure | −2.5—−0.7% | −3.4—−1.0% | −5.2—−1.7% | −3.3—−0.9% | −5.5—−1.5% | −4.4—−1.4% | −3.1—−0.9% | −8.0—−2.2% | −2.9—−1.2% | −1.7—−0.8% | |
| Intangible assets bought | — | −2.1—−0.6% | −0.5—−0.2% | — | −0.1—−0.0% | −0.3—−0.1% | −0.3—−0.1% | −0.4—−0.1% | −3.3—−1.3% | −0.1—−0.1% | |
| Acquisitions, net of cash acquired | — | — | −30—−9.4% | — | — | — | −70—−19.5% | — | −4.5—−1.8% | — | |
| Cash from investing activities | −26—−7.5% | −14—−4.2% | −59—−18.8% | −11—−2.9% | −15—−4.1% | −26—−8.3% | −44—−12.2% | −25—−7.0% | −24—−9.8% | −12—−5.9% | |
| Debt repaid | — | — | — | — | — | — | — | — | — | −0.3—−0.2% | |
| Shares issued | 27—7.8% | — | — | — | — | — | — | — | — | — | |
| Cash from financing activities | 24+9025%6.9% | 0.3−72.4%0.1% | 1.0+153%0.3% | 0.4−97.5%0.1% | 15+626%4.2% | 2.1−58.1%0.7% | 4.9−73.1%1.4% | 18+30.6%5.1% | 14+81.5%5.6% | 7.7—3.8% | |
| Change in cash | −12—−3.6% | −8.1—−2.4% | −62—−19.5% | −49−306%−12.9% | 24+69.2%6.6% | 14+893%4.5% | 1.4−97.4%0.4% | 54+7.1%15.0% | 50+87.3%20.1% | 27—13.2% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 379+13.7%100% | 77−2.4%100% | 95+3.0%100% | 85+3.4%100% | 122r82*+52.3%100% | 79r92−11.0%100% | 92+4.0%100% | 82+5.5%100% | 80*+5.5%100% | 89—100% | 89—100% | 78—100% | 76*—100% | |
| Cost of revenue | 212+15.6%55.9% | 43+0.6%55.9% | 52+1.7%54.5% | 47+2.9%55.5% | 70r46*+59.7%57.3% | 43r51−9.6%54.3% | 51+10.7%55.2% | 46+5.2%55.8% | 44*−8.3%54.7% | 47—53.5% | 46—51.9% | 44—55.9% | 48*—62.9% | |
| Gross profit | 167+11.3%44.1% | 34−6.0%44.1% | 43+4.7%45.5% | 38+4.1%44.5% | 52r35*+43.3%42.7% | 36r41−12.5%45.7% | 41−3.3%44.8% | 36+5.8%44.2% | 36*+28.9%45.3% | 41—46.5% | 43—48.1% | 34—44.1% | 28*—37.1% | |
| Research and development | 22+8.5%5.7% | 5.4+11.7%7.0% | 5.9+12.7%6.2% | 5.1+26.4%6.0% | 5.3*−9.9%4.4% | 4.8+37.6%6.1% | 5.2−7.2%5.6% | 4.0−38.7%4.9% | 5.9*−12.2%7.4% | 3.5—4.0% | 5.6—6.3% | 6.6—8.4% | 6.7*—8.8% | |
| Selling and marketing | 105+11.5%27.6% | 19−8.5%24.5% | 25−2.2%26.1% | 25+3.6%28.9% | 36r23*+50.9%29.9% | 21r25−21.7%26.1% | 25−0.9%27.5% | 24−11.8%28.9% | 24*−5.8%30.2% | 26—29.7% | 26—28.9% | 27—34.5% | 26*—33.8% | |
| General and administrative | 72+7.6%19.0% | 15−8.6%19.1% | 18+4.8%18.6% | 17+7.8%20.6% | 22r16*+24.9%18.0% | 16r18−16.2%20.4% | 17−9.1%18.3% | 16−5.2%19.7% | 18*−28.9%22.0% | 19—21.7% | 19—20.9% | 17—22.0% | 25*—32.6% | |
| Operating expenses | 209+15.6%55.1% | 50+19.2%64.2% | 48+1.9%50.9% | 47+7.2%55.5% | 64r45*+33.7%52.3% | 42r48−15.3%52.6% | 47−4.7%51.4% | 44−13.1%53.5% | 48*−16.6%59.5% | 49—55.3% | 50—56.1% | 51—64.9% | 57*—75.3% | |
| Operating income | −42—−11.0% | −16—−20.2% | −5.1—−5.4% | −9.3—−11.0% | −12r−9.3*—−9.6% | −5.4r−7.1—−6.9% | −6.1—−6.6% | −7.7—−9.3% | −11*—−14.2% | −7.8—−8.8% | −7.1—−8.0% | −16—−20.9% | −29*—−38.2% | |
| Interest and finance income | 3.8−18.6%1.0% | 0.9−18.7%1.1% | 0.9−23.3%0.9% | 0.9−14.5%1.0% | 1.2*−17.7%1.0% | 1.1+2.8%1.4% | 1.1−15.8%1.2% | 1.0−26.7%1.3% | 1.4*−11.8%1.8% | 1.0—1.2% | 1.3—1.5% | 1.4—1.8% | 1.6*—2.1% | |
| Other non-operating income (expense) | 4.8−22.1%1.3% | 0.9−43.7%1.2% | 1.1−40.1%1.1% | 0.8−39.5%1.0% | 1.9*+49.6%1.6% | 1.7−3.0%2.1% | 1.8+24.3%2.0% | 1.4−10.4%1.7% | 1.3*−31.4%1.6% | 1.7—1.9% | 1.5—1.7% | 1.5—2.0% | 1.9*—2.5% | |
| Income before tax | −37—−9.7% | −15—−19.0% | −4.0—−4.2% | −8.5—−10.0% | −9.8r−7.4*—−8.0% | −3.8r−5.4—−4.8% | −4.3—−4.7% | −6.3—−7.6% | −10*—−12.6% | −6.1—−6.8% | −5.6—−6.3% | −15—−18.9% | −27*—−35.7% | |
| Income tax | −0.4—−0.1% | 0.2—0.2% | −0.2—−0.2% | −0.2—−0.2% | −0.2*—−0.2% | −0.1—−0.2% | −0.2—−0.2% | −0.1—−0.1% | −0.3*—−0.4% | −0.1—−0.1% | −0.0—−0.0% | −0.2—−0.2% | −0.5*—−0.7% | |
| Income from continuing operations | — | −15—−19.2% | — | — | — | −3.6—−4.6% | — | — | — | — | — | — | — | |
| Income from discontinued operations | — | −1.4—−1.8% | — | — | — | −1.7—−2.1% | — | — | — | — | — | — | — | |
| Net income attributable to shareholders | −35—−9.3% | −16—−20.9% | −3.9—−4.0% | −8.3—−9.8% | −7.1*—−5.8% | −5.3—−6.7% | −4.2—−4.5% | −6.2—−7.5% | −9.8*—−12.2% | −6.0—−6.7% | −5.6—−6.3% | −15—−18.7% | −27*—−35.0% | |
| Earnings per share, basic | — | -0.61—— | -0.14—— | -0.30—— | — | -0.20—— | -0.15—— | -0.25—— | — | -0.25—— | -0.24—— | -0.62—— | — | |
| Earnings per share, diluted | — | -0.61—— | -0.14—— | -0.30—— | — | -0.20—— | -0.15—— | -0.25—— | — | -0.25—— | -0.24—— | -0.62—— | — | |
| Shares, weighted average (basic) | 26−2.3%— | 26−2.3%— | 27+0.3%— | 27+8.6%— | — | 27+14.0%— | 27+14.2%— | 25+7.5%— | — | 24—— | 24—— | 23—— | — | |
| Shares, weighted average (diluted) | 26−2.3%— | 26−2.3%— | 27+0.3%— | 27+8.6%— | — | 27+14.0%— | 27+14.2%— | 25+7.5%— | — | 24—— | 24—— | 23—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 82—30.9% | 82−23.1%30.9% | 87−15.8%30.6% | 93−21.7%32.6% | 104−8.8%34.7% | 106+0.7%34.7% | 104+5.9%33.2% | 119+10.7%38.6% | 114−9.3%38.4% | 106—34.5% | 98—31.7% | 107—34.0% | 125—38.5% | |
| Short-term investments | 15—5.7% | 15−10.5%5.7% | 18−2.6%6.4% | 17—6.0% | 16—5.3% | 17+11.8%5.5% | 19−5.2%6.0% | — | 0−100%0.0% | 15—4.9% | 20—6.4% | 12—3.9% | 3.0—0.9% | |
| Receivables | 49—18.4% | 49+20.4%18.4% | 46+19.6%16.2% | 42+14.3%14.6% | 34r39+15.5%11.4% | 40+17.9%13.2% | 39+7.1%12.4% | 37−9.0%11.9% | 30−30.0%10.0% | 34—11.2% | 36—11.7% | 40—12.7% | 42—12.9% | |
| Inventory | 29—11.0% | 29+15.8%11.0% | 29+17.8%10.0% | 25−4.9%8.7% | 26+4.7%8.7% | 25+7.5%8.2% | 24+1.1%7.8% | 26+6.8%8.5% | 25+13.6%8.4% | 23—7.6% | 24—7.8% | 25—7.8% | 22—6.7% | |
| Other current assets | 12—4.7% | 12−10.0%4.7% | 13−24.3%4.4% | 12−19.3%4.3% | 11r13−17.0%3.8% | 14+40.7%4.5% | 17+33.1%5.3% | 15+12.4%5.0% | 14r13−1.3%4.6% | 9.8—3.2% | 12—4.0% | 14—4.3% | 14—4.2% | |
| Current assets | 208—78.6% | 208+2.3%78.6% | 194−4.4%68.0% | 191−5.0%66.7% | 225r198+21.1%75.2% | 204+5.8%66.4% | 203+4.3%65.1% | 201+0.8%65.1% | 185−10.4%62.6% | 193—62.9% | 195—63.1% | 199—63.1% | 207—63.5% | |
| Property, plant and equipment | 8.6—3.3% | 8.6−76.9%3.3% | 32−20.9%11.1% | 34−18.0%11.8% | 10r36−77.3%3.4% | 37−19.9%12.2% | 40−14.6%12.9% | 41−16.6%13.3% | 44−11.8%15.0% | 47—15.2% | 47—15.2% | 49—15.6% | 50—15.4% | |
| Right-of-use (leased) assets | 14—5.3% | 14−18.0%5.3% | 15−17.1%5.2% | 16−13.2%5.5% | 17−9.8%5.5% | 17−9.6%5.6% | 18−9.9%5.8% | 18−11.9%5.9% | 18−10.0%6.2% | 19—6.2% | 20—6.5% | 21—6.5% | 20—6.2% | |
| Goodwill | 0—0.0% | 0−100%0.0% | 10−2.9%3.6% | 10+6.3%3.7% | 11+13.0%3.6% | 11+5.2%3.5% | 11+9.6%3.4% | 9.9+0.3%3.2% | 9.5−5.9%3.2% | 10—3.3% | 9.8—3.2% | 9.8—3.1% | 10—3.1% | |
| Other intangible assets | 26—9.8% | 26−18.6%9.8% | 27−17.7%9.6% | 29−8.5%10.1% | 31+0.9%10.3% | 32−5.1%10.4% | 33−0.7%10.7% | 32−4.0%10.2% | 30−11.8%10.3% | 34—11.0% | 34—10.9% | 33—10.4% | 35—10.6% | |
| Total assets | 265—100% | 265−13.7%100% | 286−8.5%100% | 286−7.3%100% | 299+0.8%100% | 307+0.3%100% | 312+1.0%100% | 308−2.3%100% | 296−9.2%100% | 306—100% | 309—100% | 316—100% | 326—100% | |
| Accounts payable | 26—10.0% | 26+24.7%10.0% | 25+15.3%8.8% | 24+3.6%8.4% | 20r20+18.8%6.6% | 21+37.2%6.9% | 22+46.0%7.0% | 23+46.1%7.5% | 17+23.5%5.6% | 15—5.0% | 15—4.9% | 16—5.0% | 13—4.1% | |
| Current liabilities | 70—26.5% | 70+8.2%26.5% | 71+5.7%24.8% | 61−6.1%21.5% | 64−17.1%21.3% | 65−10.3%21.2% | 67−7.1%21.5% | 65−11.4%21.2% | 77+5.8%25.9% | 72—23.6% | 72—23.4% | 74—23.4% | 72—22.2% | |
| Lease liabilities (non-current) | 12—4.4% | 12−22.7%4.4% | 13−21.4%4.4% | 13−17.4%4.7% | 14−13.7%4.8% | 15−13.1%4.9% | 16−11.9%5.1% | 16−12.5%5.3% | 17−9.2%5.6% | 17—5.7% | 18—5.9% | 19—5.9% | 18—5.6% | |
| Total liabilities | 108—40.7% | 108−1.7%40.7% | 111−1.6%38.8% | 103−6.7%36.0% | 106−13.0%35.6% | 110−9.1%35.8% | 113−7.2%36.1% | 110−10.7%35.8% | 122+0.8%41.3% | 121—39.4% | 121—39.3% | 124—39.2% | 121—37.2% | |
| Retained earnings | −204—−77.0% | −204—−77.0% | −188—−65.7% | −184—−64.3% | −176—−58.8% | −168—−54.9% | −163—−52.3% | −159—−51.6% | −153—−51.6% | −143—−46.7% | −137—−44.4% | −132—−41.7% | −117—−35.9% | |
| Shareholders' equity | 157—59.3% | 157−20.4%59.3% | 175−12.3%61.2% | 183−7.6%64.0% | 192+10.6%64.4% | 197+6.3%64.2% | 199+6.3%63.9% | 198+3.2%64.2% | 174−15.1%58.7% | 185—60.6% | 188—60.7% | 192—60.8% | 205—62.8% | |
| Total liabilities and equity | 265—100% | 265−13.7%100% | 286−8.5%100% | 286−7.3%100% | 299+0.8%100% | 307+0.3%100% | 312+1.0%100% | 308−2.3%100% | 296−9.2%100% | 306—100% | 309—100% | 316—100% | 326—100% | |
| Shares outstanding | 26—— | 26−3.5%— | 27−1.1%— | 27+1.8%— | 27+13.9%— | 27+14.0%— | 27+14.0%— | 27+14.2%— | 24+2.5%— | 24—— | 24—— | 24—— | 23—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 23+52.7%6.1% | 0.9−9.7%1.1% | 3.4−14.0%3.6% | 4.9−5.5%5.8% | 14r5.0*+177%11.5% | 1.0r3.9−76.9%1.2% | 4.0−3.6%4.3% | 5.2−1.4%6.3% | 5.1*−1.2%6.3% | 4.2—4.7% | 4.2—4.7% | 5.3—6.7% | 5.1*—6.8% | |
| Share-based compensation | 7.4−6.3%1.9% | 1.8+1.3%2.3% | 1.8−22.8%1.9% | 2.0−9.2%2.3% | 1.9r1.8*+11.7%1.6% | 1.7r1.8+17.7%2.2% | 2.3+26.4%2.5% | 2.1−11.1%2.6% | 1.7*—2.1% | 1.5—1.7% | 1.8—2.0% | 2.4—3.1% | — | |
| Cash from operating activities | −9.2—−2.4% | −4.5*−306%−5.8% | 2.9*−32.3%3.1% | −6.7—−7.9% | −0.9*—−0.8% | 2.2*−69.0%2.7% | 4.4*−35.0%4.7% | −17—−20.4% | −3.0*—−3.8% | 7.0*—7.9% | 6.7*—7.5% | −4.7—−6.1% | −3.1*—−4.1% | |
| Capital expenditure | −2.2—−0.6% | −0.3*—−0.4% | −0.7*—−0.7% | −0.2—−0.2% | −1.0*—−0.8% | −0.6*—−0.7% | −0.7*—−0.7% | −0.3—−0.4% | −0.3*—−0.4% | −1.7*—−1.9% | −0.1*—−0.1% | −1.3—−1.7% | −1.4*—−1.8% | |
| Intangible assets bought | — | — | — | — | — | — | — | — | 0*—0.0% | 0*—0.0% | — | — | 0*—0.0% | |
| Acquisitions, net of cash acquired | — | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | |
| Cash from investing activities | −4.4—−1.2% | 2.2*—2.8% | −3.1*—−3.3% | −2.0—−2.3% | −1.5*−113%−1.2% | −0.1*−127%−0.1% | −23*—−24.5% | −2.0—−2.5% | 12*+180%14.4% | 0.3*—0.3% | −12*—−13.9% | −13—−17.2% | 4.1*—5.4% | |
| Shares issued | — | — | — | — | 0*—0.0% | 0*—0.0% | 0*—0.0% | 27—33.1% | — | — | — | — | — | |
| Shares bought back | — | −3.7*—−4.9% | −5.6*—−5.9% | −1.9—−2.2% | — | — | — | — | — | — | — | — | — | |
| Cash from financing activities | −11−147%−3.0% | −3.4*−923%−4.5% | −5.6*—−5.9% | −2.1−109%−2.5% | −0.2*—−0.2% | 0.4*−5.2%0.5% | 0*—0.0% | 24+8304%29.1% | −0.3*—−0.3% | 0.4*—0.5% | −0.2*—−0.2% | 0.3—0.4% | −0.0*—−0.0% | |
| Change in cash | −25—−6.6% | −5.9*−309%−7.6% | −5.8*—−6.1% | −11−307%−12.5% | −2.7*−134%−2.2% | 2.8*−64.1%3.5% | −18*—−19.1% | 5.1—6.2% | 8.1*+820%10.2% | 7.8*—8.8% | −6.0*—−6.7% | −18—−23.1% | 0.9*—1.2% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Inogen, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Countries and regions
- 🇺🇸 USA$210 M60%-4.0%
- International revenue(total)$139 M40%+18%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Inogen, Inc. operates: 4 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 3 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office | $210 M60% |
| 🇫🇷 France | 1 subsidiary | — |
| 🇩🇪 Germany | 1 subsidiary | — |
| 🇳🇱 Netherlands | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Inogen, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Kevin R.M. Smith | $3.0 M | $1.9 M | $1.5 M | $15 (peers $78) |
| 2024Kevin R.M. Smith | $4.2 M | $5.4 M | $961 K | $21 (peers $78) |
| 2023Nabil Shabshab, Kevin R.M. Smith | $4.3 M | −$1.4 M | $1.1 M | $12 (peers $74) |
| 2022Nabil Shabshab | $6.3 M | $3.2 M | $2.0 M | $44 (peers $79) |
| 2021Nabil Shabshab, Scott Wilkinson | $7.0 M | $5.6 M | $1.2 M | $76 (peers $103) |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Inogen, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Acquisition or sale completed 1 · Directors and officers 12 · Material agreement 3 · Unregistered share sale 1 · Shareholder vote 3 · Results announced 13
| Filed | What happened | Filing |
|---|---|---|
| Acquisition or sale completedDirectors and officersResults announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026
Acquisitions and funding#
1 acquisitions · 1 private funding rounds before listing
Businesses it acquired
| Acquired | Acquisition date | Completion | Price | Stake | Source |
|---|---|---|---|---|---|
| Physio-Assist SAS | Sep 2023 | Sep 2023 | — | — | Annual report |
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2010 | $10 M | No. 1 | $2 to $10 million | 8 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| Not stated | Restructuring planSEC 8-K | Company-wide plan | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Inogen, Inc. compares in Medical Devices
- Market cap$173 M · higher than 40% of 142
- Revenue$349 M · higher than 64% of 155
- Net margin-10.1% · higher than 47% of 144
- Revenue growth3.9% · higher than 28% of 104
- Price / sales0.5× · lower than 95% of 96
- Price / book0.9× · lower than 87% of 99
- FCF yield-7.9% · higher than 33% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Inogen, Inc.🇺🇸 | $173 M | — | -10.1% | +3.9% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Hi-Clearance Inc.$169 M
- Easywell Biomedicals, Inc.$181 M
- Delta Asia International Corporation$162 M
- Owlet, Inc.$194 M
- RxSight, Inc.$195 M
- United Orthopedic Corporation$206 M
Sources and freshness
- Market cap:
- Oct 22, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on 2021
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Inogen, Inc.? Verify and update this profile — free
Show Inogen, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.